Industry Panel: What DE&I Means to Us

In this discussion we bring together senior leadership from leading pharmaceutical and medical device companies to talk about training, education, and clinical research opportunities for women. Learn how these companies are advancing women as thought leaders in medicine.
18 Feb 2022
9:45 am – 10:20 am
Grand Ballroom

Industry Panel: What DE&I Means to Us

Moderator: Azin Parhizgar, PhD – Senior Venture Partner | 415 Capital Management

Panelists:

  • Camille Chang Gilmore, MBA – Global Chief Diversity Officer | Boston Scientific.
  • Debbie Drane – Senior Vice-President, Global Commercial Development and TA Strategy | CSL Behring.
  • Bonnie Handke, RN, MBA – Vice-President, Healthcare Economics, Policy and Reimbursement | Medtronic.
  • Jennifer Jones-McMeans, PhD – Division Vice-President of Global Clinical Affairs | Abbott.
  • Sandra Lesenfants – President, Interventional | Penumbra.